| 000 | 01780 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518024137.0 | ||
| 264 | 0 | _c20190418 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(18)32259-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaight, Barbara R | |
| 245 | 0 | 0 |
_aEfficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. _h[electronic resource] |
| 260 |
_bLancet (London, England) _c02 2019 |
||
| 300 |
_a778-790 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xblood |
| 650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aOpioid-Related Disorders _xdrug therapy |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aPatient Satisfaction |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aLearned, Susan M | |
| 700 | 1 | _aLaffont, Celine M | |
| 700 | 1 | _aFudala, Paul J | |
| 700 | 1 | _aZhao, Yue | |
| 700 | 1 | _aGarofalo, Amanda S | |
| 700 | 1 | _aGreenwald, Mark K | |
| 700 | 1 | _aNadipelli, Vijay R | |
| 700 | 1 | _aLing, Walter | |
| 700 | 1 | _aHeidbreder, Christian | |
| 773 | 0 |
_tLancet (London, England) _gvol. 393 _gno. 10173 _gp. 778-790 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(18)32259-1 _zAvailable from publisher's website |
| 999 |
_c29399925 _d29399925 |
||